Prevalence of Hypogonadism and Associated Risk Factors Among Newly Diagnosed ART Naïve HIV-Infected Males in Mwanza, Tanzania

Overview

Journal Int J Endocrinol

Publisher Wiley

Specialty Endocrinology

Date 2024 Mar 13

PMID 38476640

Authors

Shabani Iddi

Haruna Dika

Benson Kidenya

Samuel Kalluvya

Affiliations

Soon will be listed here.

Abstract

Background: Hypogonadism is frequent among HIV-infected males and might have significant clinical impact leading to sexual impairment and metabolic derangement. There is limited information about the magnitude of hypogonadism and its associated factors among people living with HIV in Tanzania. We aimed to determine the prevalence of hypogonadism and associated risk factors among newly diagnosed ART naïve HIV-infected men in Mwanza, Tanzania.

Methods: Newly diagnosed ART naïve HIV-infected men were enrolled at Voluntary Counseling and Testing Centres of four selected hospitals in the Mwanza region and subjected to thorough clinical and general physical examination including anthropometric measurements. A prestructured questionnaire was used to collect sociodemographic characteristics and clinical data. Serum total testosterone, follicle-stimulating hormone, luteinizing hormone, and estradiol were estimated. Serum total testosterone <300 ng/dl or testosterone >300 ng/dl with high LH and FSH (compensatory hypogonadism) was taken as markers of hypogonadism. Data were analyzed using STATA version 15.

Results: Of the 388 enrolled participants, hypogonadism was found in 47.9%, with secondary hypogonadism (83.9%, 156/186) being the most frequent form. Logistic regression analysis showed a significant association between hypogonadism and CD4+ count (OR 2.0; 95% CI 1.1-3.6; =0.022), decreased libido (OR 1.6; 95% CI 1.1-2.4; =0.024), age of above 46 years (OR 2.3; 95% CI 1.1-4.6; =0.023), herbal medicine use (OR 2.4; 95% CI 1.5-3.9; < 0.001), WHO clinical stage 3 (OR 2.7; 95% CI 1.4-5.2; =0.003), and weight loss (OR 1.8; 95% CI 1.1-3.0; =0.016).

Conclusion: Hypogonadism was found in nearly half (47.9%) of ART naïve HIV-infected men. The majority (83.9%) had secondary hypogonadism. There was a significant association of hypogonadism with older age, herbal medicine use, weight loss, advanced clinical stage, CD4+ count, and decreased libido.

References

Perez I, Moreno T, Navarro F, Santos J, Palacios R . Prevalence and factors associated with erectile dysfunction in a cohort of HIV-infected patients. Int J STD AIDS. 2013; 24(9):712-5. DOI: 10.1177/0956462413482423. View

Klein R, Lo Y, Santoro N, Dobs A . Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis. 2005; 41(12):1794-803. PMC: 2426822. DOI: 10.1086/498311. View

Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L . Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab. 1996; 81(11):4051-8. DOI: 10.1210/jcem.81.11.8923860. View

Rietschel P, Corcoran C, Stanley T, Basgoz N, Klibanski A, Grinspoon S . Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis. 2000; 31(5):1240-4. DOI: 10.1086/317457. View

Meena L, Rai M, Singh S, Chakravarty J, Singh A, Goel R . Endocrine changes in male HIV patients. J Assoc Physicians India. 2011; 59:365-6, 371. View

Bajaj S, Pathak Y, Varma S, Verma S . Metabolic Status and Hypogonadism in Human Immunodeficiency Virus-infected Males. Indian J Endocrinol Metab. 2017; 21(5):684-687. PMC: 5628536. DOI: 10.4103/ijem.IJEM_127_17. View

Grinspoon S, Bilezikian J . HIV disease and the endocrine system. N Engl J Med. 1992; 327(19):1360-5. DOI: 10.1056/NEJM199211053271906. View

Dutta D, Sharma L, Sharma N, Gadpayle A, Anand A, Gaurav K . Occurrence, patterns & predictors of hypogonadism in patients with HIV infection in India. Indian J Med Res. 2017; 145(6):804-814. PMC: 5674551. DOI: 10.4103/ijmr.IJMR_1926_15. View

Roberson D, Kosko D . Men living with HIV and experiencing sexual dysfunction: an analysis of treatment options. J Assoc Nurses AIDS Care. 2013; 24(1 Suppl):S135-45. DOI: 10.1016/j.jana.2012.08.010. View

10.

Dobs A, Dempsey M, Ladenson P, Polk B . Endocrine disorders in men infected with human immunodeficiency virus. Am J Med. 1988; 84(3 Pt 2):611-6. DOI: 10.1016/0002-9343(88)90144-1. View

11.

Pongener N, Salam R, Ningshen R, Visi V, Wairokpam T, Devi L . A study on hypogonadism in male HIV patients in northeastern part of India. Indian J Sex Transm Dis AIDS. 2019; 40(1):20-24. PMC: 6532493. DOI: 10.4103/ijstd.IJSTD_67_17. View

12.

Crum N, Furtek K, Olson P, Amling C, Wallace M . A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management. AIDS Patient Care STDS. 2005; 19(10):655-71. DOI: 10.1089/apc.2005.19.655. View

13.

De Vincentis S, Decaroli M, Fanelli F, Diazzi C, Mezzullo M, Tartaro G . Primary, secondary and compensated male biochemical hypogonadism in people living with HIV (PLWH): relevance of sex hormone-binding globulin (SHBG) measurement and comparison between liquid chromatography-tandem mass spectrometry (LC-MS/MS) and.... Aging Male. 2022; 25(1):41-53. DOI: 10.1080/13685538.2022.2039116. View

14.

Fernandez C, Chacko E, Pappachan J . Male Obesity-related Secondary Hypogonadism - Pathophysiology, Clinical Implications and Management. Eur Endocrinol. 2019; 15(2):83-90. PMC: 6785957. DOI: 10.17925/EE.2019.15.2.83. View

15.

Petak S, Nankin H, Spark R, Swerdloff R, Rodriguez-Rigau L . American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. Endocr Pract. 2004; 8(6):440-56. View

16.

Rochira V, Zirilli L, Orlando G, Santi D, Brigante G, Diazzi C . Premature decline of serum total testosterone in HIV-infected men in the HAART-era. PLoS One. 2011; 6(12):e28512. PMC: 3235128. DOI: 10.1371/journal.pone.0028512. View

17.

Crum-Cianflone N, Bavaro M, Hale B, Amling C, Truett A, Brandt C . Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS. 2007; 21(1):9-19. DOI: 10.1089/apc.2006.0071. View

18.

Grinspoon S . Androgen deficiency and HIV infection. Clin Infect Dis. 2005; 41(12):1804-5. DOI: 10.1086/498320. View

19.

Peltzer K, Friend-Du Preez N, Ramlagan S, Fomundam H . Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2008; 8:255. PMC: 2503977. DOI: 10.1186/1471-2458-8-255. View

20.

Blick G . Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels. Postgrad Med. 2013; 125(2):30-9. DOI: 10.3810/pgm.2013.03.2639. View